FutureFuel (FF) risk factors, FY2025 10-K

FutureFuel's FY2025 10-K, filed Mar 16, 2026, lists 133 risk factors. Against the prior year's 126: 35 new, 28 dropped, 66 substantially reworded.

Open FF in Gloom →
FutureFuel's chart, financials and news, free in your browser.Open FF in Gloom →
Risk factors listed
1330 groups
New this year
35vs 126 last year
Dropped
28since the prior 10-K
Substantially reworded
66of those kept
Section length
34k wordsItem 1A

What the changes say

  • FutureFuel faced severe gross margin compression due to regulatory ambiguity surrounding the CFPC and operational delays at its Batesville facility.

What changed since the prior 10-K

New

  • New

    The Company’s common stock is its only class of equity securities registered under Section 12 of the Exchange Act. During the fiscal year ended December 31, 2025, neither the Company nor any affiliated purchasers acquired any shares of our common stock

  • New

    Program Extension: On December 10, 2025, the Company announced a 24-month extension of this $25.0 million authorization. The program is now scheduled to expire on March 31, 2028

  • New

    Management ’ s Discussion and Analysis of Financial Condition and Results of Operations

  • New

    Program Flux: Ongoing shifts in the federal renewable fuels program continue to impact our revenue projections

    Ongoing shifts in federal renewable fuels programs and government subsidies favoring renewable diesel and electric vehicles create headwinds for biodiesel operations.

  • New

    For a detailed analysis of these variables, please refer to "Risk Factors" and Note 3 of our consolidated financial statements

  • New

    $ 367,368 $ 882 $ 368,250

  • New

    $ (49,397 ) $ 15,503 $ (64,900 ) NA

  • New

    $ (38,317 ) $ 21,317 $ (59,634 ) NA

  • New

    Regulatory Uncertainty: The downturn is largely attributed to ongoing market ambiguity surrounding the CFPC, which materially impacted production economics

    Market ambiguity surrounding the CFPC severely impacted production economics, prompting the company to idle the biodiesel plant and reduce headcount.

  • New

    Chemicals Segment Revenue Impact

    Weather complications extended the scheduled plant turnaround at the chemicals segment, causing a $14,382 decline in sales volume.

  • New

    Contractual Transition: A $5,492 reduction in the amortization of deferred revenue following the 2024 expiration of a long-term contract. While the customer relationship continues, it has transitioned to a short-term contractual framework

  • New

    Biofuels Segment: Contributed ($23,430) to the decrease

  • New

    Operational Idling & Market Uncertainty: Significant volume losses in biodiesel and its byproduct, glycerin, followed the strategic decision to idle biodiesel production in June 2025. This proactive measure was taken in response to persistent regulatory ambiguity surrounding the CFPC

  • New

    Inventory Accounting (LIFO): Valuation adjustments under the Last-In, First-Out (“LIFO”) method negatively impacted gross profit by $1,706 in 2025, a significant reversal from the $3,028 gain recognized through LIFO in 2024

  • New

    Strategic Offset: These decreases were partially mitigated by the successful launch and sale of a new energy-market product following the completion of a major chemical production construction project

  • New

    The decline in performance is attributable to an extended plant turnaround initiated to enhance long-term reliability, followed by the subsequent strategic decision to idle production due to regulatory uncertainty surrounding the CFPC and other adverse market conditions

  • New

    Contractual Flexibility: Our sales are typically executed through short-term purchase orders at prevailing market rates rather than long-term, fixed-volume obligations

  • New

    Inventory Valuation (LIFO): Adjustments to the carrying value of inventory under the LIFO method negatively impacted gross profit by $1,739 in 2025, a sharp reversal from the $2,370 gain recognized in 2024

  • New

    Cash used in investing activities was $18,601 in 2025 compared to $14,794 in 2024 for a net decrease in cash of $3,807. This decrease in cash was primarily attributable to increased capital expenditures of $2,579 and the change in the collateralization of derivative instruments of $1,256

  • New

    Accounts receivable – related parties

  • New

    BIODIESEL BLENDERS' TAX CREDIT

  • New

    SMALL AGRI-BIODIESEL PRODUCER TAX CREDIT (SAPC)

  • New

    CLEAN FUEL PRODUCTION TAX CREDIT (CFPC)

  • New

    TRANSFERABLE TAX CREDITS (SAPC and CFPC)

  • New

    165 $ ( 13 ) 100 $ ( 235 )

  • New

    On December 31, 2025 and 2024, there were no right of use assets reported on the balance sheet

  • New

    The Company prospectively adopted ASU No. 2023 - 09 (see Note 2 for further details) which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional disclosure on income taxes paid

  • New

    The Company's effective tax rate for 2025 reflects the positive effect of the CFPC, new in 2025, and the Small Agri-biodiesel Producer Tax Credit that was reinstated with the Budget Reconciliation Act of 2025 and extended through December 31, 2026

  • New

    There are no unrecognized tax positions as of December 31, 2025 , 2024 , or 2023

  • New

    $ 59,565 $ 36,177 $ 95,742

  • New

    $ ( 13,007 ) $ ( 26,418 ) $ ( 39,425 )

  • New

    Our board believes that Ms. Butcher’s extensive managerial and leadership experience in the chemical industry adds significant value to our board and the Company

  • New

    Our executive officers generally participate in employee welfare plans (life insurance, medical insurance, disability insurance, vacation pay, and the like) maintained by FutureFuel Chemical Company for all of its employees

  • New

    N/A N/A N/A N/A N/A 5,012 $ 16

  • New

    (d) In November 2025, we granted annual stock awards of 5,000 restricted shares to each member of the Board of Directors pursuant to the Incentive Plan. The restricted shares vest in four equal installments beginning March 31, 2026 and ending on November 18, 2026

Dropped

  • Dropped

    Purchase of Securities by Us

  • Dropped

    The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the Notes thereto, set forth herein

  • Dropped

    $ 394,671 $ 1,343 $ 396,014

  • Dropped

    $ 17,594 $ 34,983 $ (17,389 ) (50 )%

  • Dropped

    Operating expenses decreased $339 in 2024 compared to 2023. This decrease was primarily the result of decreased research and development and legal expenses

  • Dropped

    Consolidated sales revenue decreased 7.0% or $27,764 in 2023 compared to 2022 primarily from lower average sales prices in the biofuel segment ($71,198) and, to a lesser extent, in the chemical segment ($1,916). This decrease was partially offset by higher biodiesel sales volumes in the biofuel segment ($44,994)

  • Dropped

    The income tax provision was $1 in 2023 or an effective tax rate of 0.0% as compared to a benefit in 2022 of ($1,473) or an effective tax rate of (10.7%)

  • Dropped

    Biofuels sales revenue decreased 8.3% or $26,204 in 2023 compared to 2022, primarily from decreased selling prices of biodiesel and biodiesel blends, inclusive of a decline in separated RIN sale prices. RIN prices declined during 2023 as production levels exceeded the renewable volume obligations set by the EPA

  • Dropped

    In 2023, we paid regular cash dividends aggregating $0.24 per share on our common stock with record dates and payment dates as previously discussed. The regular cash dividends declared in 2023 totaled $10,503 to be paid in 2024

  • Dropped

    Revenue recognition – Recognition of material rights consideration

  • Dropped

    We obtained the contracts with customers containing material rights and evaluated for the proper accounting treatment

  • Dropped

    We evaluated the appropriateness of expected contractual volumes to be sold over the remaining contract life which included comparing the estimated volumes to customer forecasts

  • Dropped

    Gain (loss) on marketable securities

  • Dropped

    $ 15,503 $ 37,382 $ 15,211

  • Dropped

    Accrued expenses and other current liabilities – related parties

    Biofuels sales revenue decreased due to lower selling prices and RIN sale prices.

  • Dropped

    Change in Accounting Principle

  • Dropped

    The Company received the BTC which provided a one dollar per gallon tax credit to the blender of biomass-based diesel with at least 0.1% petroleum-based diesel fuel. The Company recorded this credit as a reduction to cost of goods sold as applicable sales were made

  • Dropped

    The IRA created the clean fuel production credit (“CFPC”) for qualifying transportation fuel produced after 2024 and sold on or before December 31, 2027. The CFPC consolidates and replaces several fuel related credits which expired December 31, 2024 including the BTC and the Small Agri-biodiesel Producer Tax Credit

    Regular cash dividends paid on common stock.

  • Dropped

    At December 31, 2024 and 2023, the Company held no marketable equity or trust preferred (debt) securities. The previous sale of these securities was recorded as a component of net income with a gain of $575 in the year ended December 31, 2023

  • Dropped

    Other current assets primarily comprise supplies and parts which are held in support of maintenance and repair of plant equipment. The balance related to these items totaled $7,733 and $7,595 at December 31, 2024 and 2023, respectively

  • Dropped

    The income tax provision in 2024 was $792 or an effective tax rate of 4.9% as compared to an income tax provision of $1 or an effective tax rate of 0.0% in 2023 and an income tax benefit of $1,473 or an effective tax rate of (10.7%) in 2022

  • Dropped

    There are no unrecognized tax positions as of December 31, 2024, 2023, or 2022, and the Company does not anticipate any change over the next twelve months

  • Dropped

    5,000 shares of restricted stock were awarded in December 2024 to each of the eight members of the Board of Directors for a total of 40,000 shares. The awards vested immediately and had a compensation expense of $206

    Revenue recognition of material rights consideration under ASC Topic 606.

  • Dropped

    In 2023, the Company did not make any grants under the Incentive Plan

  • Dropped

    $ 80,893 $ 315,121 $ 396,014

  • Dropped

    $ 25,645 $ 3,348 $ 28,993

  • Dropped

    Life Insurance and Other Employee Benefits

  • Dropped

    N/A N/A N/A N/A N/A 750,000 $ 3,976,500

Reworded

  • 100% rewritten

    Gain on marketable securities

    Updated results of operations table to reflect a net loss of $(49,397) for the fiscal year ended December 31, 2025.

  • 100% rewritten

    $ ( 49,397 ) $ 15,503 $ 37,382

    Was: $ 15,503 $ 37,382 $ (21,879 ) (59 )%

  • 100% rewritten

    (Dollars in thousands, except per share amounts)

  • 100% rewritten

    New accounting standards adopted

    Was: Recently adopted accounting standards

  • 100% rewritten

    Our board believes that Mr. Rowe's extensive managerial and leadership experience in the chemical industry adds significant value to our board and the Company

    Updated board of directors background to reflect the appointment of Pamela R. Butcher in April 2025.

  • 98% rewritten

    The Company recognizes compensation expense in its financial statements for common stock-based options, stock units, and stock awards based upon the grant-date fair value over the requisite service period

    Updated stock incentive disclosures to reflect 2025 grants of 10,000 stock options to a new director and 40,000 restricted shares to the Board.

  • 97% rewritten

    Revenue – related parties

    Updated financial figures to report a gross loss of $(39,425) and operating loss of $(52,990) for 2025.

  • 95% rewritten

    New accounting standards issued but not yet adopted

    Was: Issued accounting standards not yet adopted

  • 94% rewritten

    Operating expenses increased $293 in 2025 compared to 2024. This increase was primarily the result of increased executive compensation expense

    Was: Operating expenses increased $2,164 in 2023 compared to 2022. This increase was primarily the result of increased compensation expense

  • 94% rewritten

    Loss on the sale of investments

  • 93% rewritten

    $ 29,936 $ 11,043 $ 40,979

  • 93% rewritten

    PROPERTY, PLANT, AND EQUIPMENT

  • 88% rewritten

    Pricing for the other performance chemical products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes

  • 84% rewritten

    Change in fair value of equity securities

  • 84% rewritten

    Cash and cash equivalents

  • 83% rewritten

    Compensation of Directors

  • 82% rewritten

    The income tax provision was $165 in 2025 or an effective tax rate of (0.3%) as compared to a provision in 2024 of $792 or an effective tax rate of 4.9%

    Was: The income tax provision was $792 in 2024 or an effective tax rate of 4.9% as compared to a provision in 2023 of $1 or an effective tax rate of 0.0%

  • 82% rewritten

    $ ( 49,232 ) $ 16,295 $ 37,383

    Was: $ 16,295 $ 37,383 $ 13,738

  • 82% rewritten

    Identification of Directors

  • 81% rewritten

    Lease commitments and purchase obligations

  • 78% rewritten

    In the years ended December 31, 2025, 2024 and 2023, the Company used the treasury method in computing earnings per share as all shares with participating security holders had vested

    Was: In the years ended December 31, 2024, 2023 and 2022, the Company used the treasury method in computing earnings per share as all shares with participating security holders had vested

  • 75% rewritten

    Related party income statement accounts

  • 74% rewritten

    Executive officers of FutureFuel Chemical Company for the years indicated

  • 74% rewritten

    Dividends received deduction

  • 72% rewritten

    Recommendations from Management

  • 68% rewritten

    Opinion on the Financial Statements

  • 65% rewritten

    Security Ownership of Certain Beneficial Owners

  • 64% rewritten

    Forfeitures for RSU grants are recognized as they occur

  • 64% rewritten

    Cash Salaries and Bonuses

  • 61% rewritten

    The Compensation Committee

  • 60% rewritten

    Total unrealized gain (loss), net of tax

  • 57% rewritten

    Transaction price allocated to the remaining performance obligations of contract liabilities

    Was: Transaction price allocated to the remaining performance obligations

  • 56% rewritten

    Proceeds from the sale of marketable securities

  • 54% rewritten

    $ 95,742 $ 243,339 $ 368,250

    Was: $ 243,339 $ 368,250 $ 396,014

  • 54% rewritten

    Cost of goods sold and distribution

  • 53% rewritten

    ACCRUED EXPENSES AND OTHER LIABILITIES

    Was: ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

  • 51% rewritten

    Securities Authorized for Issuance Under Equity Compensation Plans

  • 51% rewritten

    Compensation Committee Interlocks and Insider Participation

  • 49% rewritten

    Our board believes that Mr. Polet's extensive experience in the chemical industry, including his managerial and leadership experience, adds significant value to our board and the Company

    Was: Our board believes that Mr. Polet's extensive experience in the chemical industry, including his managerial and leadership experience, adds significant value to our company

  • 48% rewritten

    The Company leases warehouse space under a short-term lease agreement with a term of twelve months. Lease revenue recognized under this agreement was $ 680 and $ 669 for the years ended December 31, 2025 and 2024, respectively

    Was: The Company leases warehouse space under a short-term lease agreement with a term of twelve months. Lease revenue recognized under this agreement was $669 for the year ended December 31, 2024

  • 47% rewritten

    There were no stock options exercised in 2025, 2024 or 2023

    Was: There were no stock options exercised in 2024, 2023 or 2022

  • 47% rewritten

    43,861,438 43,765,757 43,763,243

    Was: 43,765,757 43,763,243 43,763,243

  • 46% rewritten

    Useful Lives of Property, Plant, and Equipment

  • 44% rewritten

    Related party transactions

  • 43% rewritten

    Asset retirement obligations and environmental costs

  • 42% rewritten

    Security Ownership of Management

  • 42% rewritten

    Defined contribution savings plan

  • 42% rewritten

    Asset retirement obligations and environmental reserves

  • 42% rewritten

    Omnibus Incentive Plan (incorporated by reference to Appendix A to Schedule 14A filed July 26,2017)

  • 40% rewritten

    Represents the grant date valuation of the awards under ASC Topic 718, Stock Compensation . Assumptions used for determining the value of awards reported here are set forth in Note 17 to our consolidated financial statements included elsewhere herein

  • 40% rewritten

    Grants of Plan-Based Awards

  • 38% rewritten

    Securities Authorized for Issuance Under Equity Compensation Plan

  • 37% rewritten

    Selling, general, and administrative expenses

  • 37% rewritten

    $ 22,632 $ ( 2,988 ) $ 19,644

  • 36% rewritten

    (a) Volume requirements and average price information are based upon volumes used and prices obtained for the year ended December 31, 2025. Volume requirements may differ materially from these quantities in future years as our business evolves

    Was: (a) Volume requirements and average price information are based upon volumes used and prices obtained for the year ended December 31, 2024. Volume requirements may differ materially from these quantities in future years as our business evolves

  • 34% rewritten

    Rose M. Sparks, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer

  • 34% rewritten

    List separately all financial statements filed as part of this report

  • 32% rewritten

    We had $4,302 of ne w chemical production equipment and infrastructure capital repair projects that generated commitments as of December 31, 2025. We plan to continue to invest in capital infrastructure to increase the reliability of plant operations

    Was: We had $1,460 of new chemical production equipment and infrastructure capital repair projects that generated commitments as of December 31, 2024. We plan to continue to invest in capital infrastructure to increase the reliability of plant operations

  • 30% rewritten

    Compensation Committee Report

  • 28% rewritten

    50,000 2.86 6.32 50,000 6.32

    Was: 44,000 3.20 7.33 44,000 7.33

  • 26% rewritten

    Nominating/Corporate Governance Committee

  • 25% rewritten

    Capital loss and charitable contribution carryforwards were generated in 2020 through 2025 and will expire in 2026 through 2030

    Was: Capital loss and charitable contribution carryforwards were generated in 2020 through 2024 and will expire in 2025 through 2029

  • 24% rewritten

    Identification of Executive Officers

  • 22% rewritten

    Accounts receivable and allowance for credit losses

  • 21% rewritten

    Research and development expenses

  • 21% rewritten

    Market risk represents the potential loss arising from adverse changes in market rates and prices. Commodity price risk is inherent in the chemical and biofuels business both with respect to input (electricity, coal, raw materials, biofuel feedstocks, etc.) and output (manufactured chemicals and biofuels)

All 133 risk factors

Headings as the filing states them, in filing order.

Other

  1. 01Securities Authorized for Issuance Under Equity Compensation Plan38% rewritten
  2. 02The Company’s common stock is its only class of equity securities registered under Section 12 of the Exchange Act. During the fiscal year ended December 31, 2025, neither the Company nor any affiliated purchasers acquired any shares of our common stockNew
  3. 03Program Extension: On December 10, 2025, the Company announced a 24-month extension of this $25.0 million authorization. The program is now scheduled to expire on March 31, 2028New
  4. 04Management ’ s Discussion and Analysis of Financial Condition and Results of OperationsNew
  5. 05Pricing for the other custom manufacturing products is negotiated directly with the customer. Some, but not all, of these products have pricing mechanisms and/or protections against raw material, energy, or conversion cost changes
  6. 06Pricing for the other performance chemical products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes88% rewritten
  7. 07Program Flux: Ongoing shifts in the federal renewable fuels program continue to impact our revenue projectionsNew
  8. 08For a detailed analysis of these variables, please refer to "Risk Factors" and Note 3 of our consolidated financial statementsNew
  9. 09$ 367,368 $ 882 $ 368,250New
  10. 10$ (49,397 ) $ 15,503 $ (64,900 ) NANew
  11. 11$ (38,317 ) $ 21,317 $ (59,634 ) NANew
  12. 12Regulatory Uncertainty: The downturn is largely attributed to ongoing market ambiguity surrounding the CFPC, which materially impacted production economicsNew
  13. 13Chemicals Segment Revenue ImpactNew
  14. 14Contractual Transition: A $5,492 reduction in the amortization of deferred revenue following the 2024 expiration of a long-term contract. While the customer relationship continues, it has transitioned to a short-term contractual frameworkNew
  15. 15Biofuels Segment: Contributed ($23,430) to the decreaseNew
  16. 16Operational Idling & Market Uncertainty: Significant volume losses in biodiesel and its byproduct, glycerin, followed the strategic decision to idle biodiesel production in June 2025. This proactive measure was taken in response to persistent regulatory ambiguity surrounding the CFPCNew
  17. 17Inventory Accounting (LIFO): Valuation adjustments under the Last-In, First-Out (“LIFO”) method negatively impacted gross profit by $1,706 in 2025, a significant reversal from the $3,028 gain recognized through LIFO in 2024New
  18. 18Operating expenses increased $293 in 2025 compared to 2024. This increase was primarily the result of increased executive compensation expense94% rewritten
  19. 19The income tax provision was $165 in 2025 or an effective tax rate of (0.3%) as compared to a provision in 2024 of $792 or an effective tax rate of 4.9%82% rewritten
  20. 20Strategic Offset: These decreases were partially mitigated by the successful launch and sale of a new energy-market product following the completion of a major chemical production construction projectNew
  21. 21The decline in performance is attributable to an extended plant turnaround initiated to enhance long-term reliability, followed by the subsequent strategic decision to idle production due to regulatory uncertainty surrounding the CFPC and other adverse market conditionsNew
  22. 22Contractual Flexibility: Our sales are typically executed through short-term purchase orders at prevailing market rates rather than long-term, fixed-volume obligationsNew
  23. 23Inventory Valuation (LIFO): Adjustments to the carrying value of inventory under the LIFO method negatively impacted gross profit by $1,739 in 2025, a sharp reversal from the $2,370 gain recognized in 2024New
  24. 24Useful Lives of Property, Plant, and Equipment46% rewritten
  25. 25Cash used in investing activities was $18,601 in 2025 compared to $14,794 in 2024 for a net decrease in cash of $3,807. This decrease in cash was primarily attributable to increased capital expenditures of $2,579 and the change in the collateralization of derivative instruments of $1,256New
  26. 26We had $4,302 of ne w chemical production equipment and infrastructure capital repair projects that generated commitments as of December 31, 2025. We plan to continue to invest in capital infrastructure to increase the reliability of plant operations32% rewritten
  27. 27Off-Balance Sheet Arrangements
  28. 28Market risk represents the potential loss arising from adverse changes in market rates and prices. Commodity price risk is inherent in the chemical and biofuels business both with respect to input (electricity, coal, raw materials, biofuel feedstocks, etc.) and output (manufactured chemicals and biofuels)21% rewritten
  29. 29(a) Volume requirements and average price information are based upon volumes used and prices obtained for the year ended December 31, 2025. Volume requirements may differ materially from these quantities in future years as our business evolves36% rewritten
  30. 30Opinion on the Financial Statements68% rewritten
  31. 31Revenue – related parties97% rewritten
  32. 32Gain on marketable securities100% rewritten
  33. 33Total unrealized gain (loss), net of tax60% rewritten
  34. 34$ ( 49,397 ) $ 15,503 $ 37,382100% rewritten
  35. 35Change in fair value of equity securities84% rewritten
  36. 36Loss on the sale of investments94% rewritten
  37. 37Accounts receivable – related partiesNew
  38. 38Proceeds from the sale of marketable securities56% rewritten
  39. 39Cash and cash equivalents84% rewritten
  40. 40Accounts receivable and allowance for credit losses22% rewritten
  41. 41Property, plant, and equipment, net
  42. 42Asset retirement obligations and environmental costs43% rewritten
  43. 43(Dollars in thousands, except per share amounts)100% rewritten
  44. 44Cost of goods sold and distribution54% rewritten
  45. 45Selling, general, and administrative expenses37% rewritten
  46. 46Research and development expenses21% rewritten
  47. 47New accounting standards adopted100% rewritten
  48. 48New accounting standards issued but not yet adopted95% rewritten
  49. 49BIODIESEL BLENDERS' TAX CREDITNew
  50. 50SMALL AGRI-BIODIESEL PRODUCER TAX CREDIT (SAPC)New
  51. 51CLEAN FUEL PRODUCTION TAX CREDIT (CFPC)New
  52. 52TRANSFERABLE TAX CREDITS (SAPC and CFPC)New
  53. 53CARES ACT – EMPLOYEE RETENTION TAX CREDIT
  54. 54The majority of revenue is from contracts with less than one -year arrangements with revenue recognized when a single performance obligation to transfer product under the terms of a contract with a customer is satisfied
  55. 55The Company leases warehouse space under a short-term lease agreement with a term of twelve months. Lease revenue recognized under this agreement was $ 680 and $ 669 for the years ended December 31, 2025 and 2024, respectively48% rewritten
  56. 56Transaction price allocated to the remaining performance obligations of contract liabilities57% rewritten
  57. 57$ 95,742 $ 243,339 $ 368,25054% rewritten
  58. 58165 $ ( 13 ) 100 $ ( 235 )New
  59. 59PROPERTY, PLANT, AND EQUIPMENT93% rewritten
  60. 60ACCRUED EXPENSES AND OTHER LIABILITIES53% rewritten
  61. 61Asset retirement obligations and environmental reserves42% rewritten
  62. 62Lease commitments and purchase obligations81% rewritten
  63. 63On December 31, 2025 and 2024, there were no right of use assets reported on the balance sheetNew
  64. 64The Company prospectively adopted ASU No. 2023 - 09 (see Note 2 for further details) which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional disclosure on income taxes paidNew
  65. 65$ ( 49,232 ) $ 16,295 $ 37,38382% rewritten
  66. 66Dividends received deduction74% rewritten
  67. 67The Company's effective tax rate for 2025 reflects the positive effect of the CFPC, new in 2025, and the Small Agri-biodiesel Producer Tax Credit that was reinstated with the Budget Reconciliation Act of 2025 and extended through December 31, 2026New
  68. 68Capital loss and charitable contribution carryforwards were generated in 2020 through 2025 and will expire in 2026 through 203025% rewritten
  69. 69There are no unrecognized tax positions as of December 31, 2025 , 2024 , or 2023 New
  70. 70In the years ended December 31, 2025, 2024 and 2023, the Company used the treasury method in computing earnings per share as all shares with participating security holders had vested78% rewritten
  71. 7143,861,438 43,765,757 43,763,24347% rewritten
  72. 72Provide incentives to persons who are not the Company employees to promote the Company’s success
  73. 73The Company recognizes compensation expense in its financial statements for common stock-based options, stock units, and stock awards based upon the grant-date fair value over the requisite service period98% rewritten
  74. 74There were no stock options exercised in 2025, 2024 or 202347% rewritten
  75. 75Forfeitures for RSU grants are recognized as they occur64% rewritten
  76. 7650,000 2.86 6.32 50,000 6.3228% rewritten
  77. 77Defined contribution savings plan42% rewritten
  78. 78Related party transactions44% rewritten
  79. 79Related party income statement accounts75% rewritten
  80. 80Biodiesel, petrodiesel, blends, and other petroleum products
  81. 81Distribution and related services
  82. 82Commodity trading advisory fees
  83. 83Travel and administrative services
  84. 84Income tax and consulting services
  85. 85$ 59,565 $ 36,177 $ 95,742New
  86. 86$ ( 13,007 ) $ ( 26,418 ) $ ( 39,425 )New
  87. 87$ 80,007 $ 163,332 $ 243,339
  88. 88$ 22,632 $ ( 2,988 ) $ 19,64437% rewritten
  89. 89$ 79,333 $ 288,917 $ 368,250
  90. 90$ 29,936 $ 11,043 $ 40,97993% rewritten
  91. 91Evaluation of Disclosure Controls and Procedures
  92. 92Management ’ s Annual Report on Internal Control Over Financial Reporting
  93. 93Changes in Internal Control Over Financial Reporting
  94. 94Opinion on the Internal Control Over Financial Reporting
  95. 95Definition and Limitations of Internal Control Over Financial Reporting
  96. 96Identification of Directors82% rewritten
  97. 97Identification of Executive Officers24% rewritten
  98. 98Our board believes that Mr. Kruszewski’s extensive managerial and leadership experience in the financial services industry in addition to a comprehensive understanding and knowledge of public companies’ day-to-day operations and strategy add significant value to our board and the Company
  99. 99Our board believes that Mr. Greer's extensive managerial and leadership experience in the chemical industry add significant value to our board and the Company
  100. 100Our board believes that Mr. Rowe's extensive managerial and leadership experience in the chemical industry adds significant value to our board and the Company100% rewritten
  101. 101Our board believes that Ms. Butcher’s extensive managerial and leadership experience in the chemical industry adds significant value to our board and the CompanyNew
  102. 102Our board believes that Mr. Polet's extensive experience in the chemical industry, including his managerial and leadership experience, adds significant value to our board and the Company49% rewritten
  103. 103Code of Business Conduct and Ethics
  104. 104Nominating/Corporate Governance Committee26% rewritten
  105. 105Compensation Discussion and Analysis
  106. 106Cash Salaries and Bonuses64% rewritten
  107. 107Provide incentives to persons who are not our employees to promote our success
  108. 108The Administrator may grant cumulative performance vested options. Performance will be tied to cumulative cash flow in amounts to be determined for periods to be determined
  109. 109Such options will vest and expire (including on a pro rata basis) on such terms as may be determined by the Administrator from time to time consistent with the terms of the Incentive Plan
  110. 110Federal Income Tax Consequences of the Incentive Plan
  111. 111Our executive officers generally participate in employee welfare plans (life insurance, medical insurance, disability insurance, vacation pay, and the like) maintained by FutureFuel Chemical Company for all of its employeesNew
  112. 112The Compensation Committee61% rewritten
  113. 113Recommendations from Management72% rewritten
  114. 114Executive officers of FutureFuel Chemical Company for the years indicated74% rewritten
  115. 115Represents the grant date valuation of the awards under ASC Topic 718, Stock Compensation . Assumptions used for determining the value of awards reported here are set forth in Note 17 to our consolidated financial statements included elsewhere herein40% rewritten
  116. 116Grants of Plan-Based Awards40% rewritten
  117. 117N/A N/A N/A N/A N/A 5,012 $ 16New
  118. 118Potential Payments upon Termination or Change in Control
  119. 119Compensation of Directors83% rewritten
  120. 120(d) In November 2025, we granted annual stock awards of 5,000 restricted shares to each member of the Board of Directors pursuant to the Incentive Plan. The restricted shares vest in four equal installments beginning March 31, 2026 and ending on November 18, 2026New
  121. 121Compensation Committee Interlocks and Insider Participation51% rewritten
  122. 122Compensation Committee Report30% rewritten
  123. 123Securities Authorized for Issuance Under Equity Compensation Plans51% rewritten
  124. 124Security Ownership of Certain Beneficial Owners65% rewritten
  125. 125Security Ownership of Management42% rewritten
  126. 126Includes 750,000 RSUs subject to certain vesting conditions, of which 95,478 RSUs have vested
  127. 127Transactions with Related Persons
  128. 128Review, Approval, or Ratification of Transactions with Related Persons
  129. 129List separately all financial statements filed as part of this report34% rewritten
  130. 130FutureFuel Corp.’s Bylaws (incorporated by reference to Exhibit No. 3.2.a to Form 10 filed April 24, 2007)
  131. 131Omnibus Incentive Plan (incorporated by reference to Appendix A to Schedule 14A filed July 26,2017)42% rewritten
  132. 132Management contract or compensatory plan or arrangement
  133. 133Rose M. Sparks, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer34% rewritten

Other FutureFuel 10-Ks

  • FY2024 10-K risk factors
    126 risks

    FutureFuel Corp. operates in chemicals and biofuels with significant focus on raw material volatility and regulatory tax credits.

    Filed Mar 31, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.